- Randomized, triple-blinded, placebo-controlled two-centre trial of 80 adults undergoing primary breast cancer surgery, with or without axillary dissection.
- Patients received either an ultrasound-guided erector spinae plane block (n=40) or intraoperative IV lidocaine infusion (n=40), both within a standardized multimodal analgesic protocol.
- The 24-hour QoR15 score was 137.7 (SD 17.9) with ESPB versus 136.3 (SD 8.8) with IVLI, p=0.61.
- Pain scores, opioid use and rescue analgesia were similarly low in both groups, and the authors suggest IVLI may be a pragmatic option when regional expertise is limited.
Regional
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Open-label multicentre randomised trial across 15 UK thoracic centres included 737 adults undergoing thoracotomy in the modified intention-to-treat population.
- The paravertebral group received three single-shot injections before incision plus a catheter, compared with a thoracic epidural catheter loaded with local anaesthetic before incision.
- Chronic post-thoracotomy pain at six months did not differ significantly, at 22% versus 16% (adjusted RR 1.32, 95% CI 0.93 to 1.86, P=0.12).
- Paravertebral blockade had less hypotension (12% vs 18%) and pruritus but more urinary retention (12% vs 6%), and day 1 acute pain was higher with paravertebral blockade.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- Randomized, patient- and assessor-blinded trial of 89 analyzed adults undergoing elective septorhinoplasty at a single tertiary training hospital.
- Bilateral ultrasound-guided infraorbital nerve block was compared with bilateral transnasal sphenopalatine ganglion block, both using 2 mL of 0.5% bupivacaine per side.
- Total QoR-15 at 24 h was higher with infraorbital block (129.1 vs 116.6; mean difference 12.5, 95% CI 8.01 to 17.01; P = 0.001), above the prespecified MCID of 8.
- Fewer infraorbital patients needed rescue morphine (11.4% vs 53.3%; P = 0.001), while nausea, anesthetic consumption and recovery room stay did not differ; authors call secondary findings hypothesis-generating.
AI summary not available. Read the source abstract on PubMed.
- Randomised, quadruple-blind trial of 90 patients aged 65-100 undergoing primary total knee arthroplasty, comparing dexamethasone adjuncts to adductor canal and iPACK blocks.
- Perineural dexamethasone (4 mg total, 2 mg per block) with ropivacaine was compared with intravenous dexamethasone 4 mg and with placebo.
- Median time to first rescue opioid was 4.5 h with placebo, 13.9 h with IV dexamethasone and 18.5 h with perineural dexamethasone (log-rank p < 0.001).
- Perineural dexamethasone produced lower opioid use than IV at later timepoints, and no motor weakness or nerve injury was reported.
- Triple-blinded randomised controlled trial of 90 patients (45 per group) having total knee arthroplasty under spinal anaesthesia with a femoral triangle block.
- Compared IPACK with 19 ml ropivacaine 0.2% against selective tibial nerve block with 5 ml ropivacaine 0.75%.
- Cumulative intravenous morphine use on postoperative day 1 was similar: 6 (SD 7) mg with IPACK versus 5 (SD 6) mg with tibial block (p = 0.36).
- Four patients (9%) in the tibial block group had common peroneal nerve motor block, and no other secondary outcome differed; the authors concluded the two techniques give similar analgesia.
- Single-center, single-blind randomized trial in a French cardiac surgery center enrolling 128 adults undergoing elective cardiac surgery with cardiopulmonary bypass, 126 analyzed.
- Patients received bilateral ultrasound-guided deep parasternal intercostal plane blocks with 40 mL ropivacaine versus standard care.
- The primary outcome, Quality of Recovery-15 at 24 hours, did not differ significantly (mean difference 3.9 points, 95% CI -3.3 to 11.2; p = 0.230), though resting pain was lower with the block at hours 2, 6, and 48.
- The authors conclude the block did not improve 24-hour recovery in mixed patients, and a non-prespecified subgroup analysis in internal mammary artery harvesting patients (n = 71) suggested possible benefit needing confirmation.
- This prospective randomized trial enrolled 271 adults undergoing elective sternotomy at a single center, randomized 1:1:1 to standard therapy, ESP block, or SPIP block.
- Both fascial plane blocks were added to a multimodal analgesic regimen and compared with the control group receiving standard therapy alone.
- Opioid use did not differ significantly on postoperative days 0 to 2; a day 3 difference favored ESP (p = 0.047). Maximum pain scores were lower in both block groups on days 0 to 3 (POD 1 p < 0.001, POD 2 p < 0.001, POD 3 p = 0.002).
- The authors conclude that patients undergoing sternotomy may benefit from adding either ESP or SPIP blocks to a multimodal postoperative regimen.
- Randomised, triple-blinded trial of 80 patients undergoing anterior cruciate ligament reconstruction under general anaesthesia with a femoral triangle block.
- Compared IPACK with 20 ml ropivacaine 0.2% against a selective tibial nerve block with 5 ml ropivacaine 0.75%, with the same multimodal postoperative analgesia in both groups.
- Median 24-hour morphine consumption was 12 mg (IQR 6-20) with IPACK versus 16 mg (IQR 10-30) with tibial block, not statistically significant (p = 0.073).
- No significant differences were found in secondary pain or functional outcomes, and no complications were reported; the authors conclude the two blocks give comparable analgesia.
- Multicenter randomized non-inferiority trial of 210 children under 2 years undergoing single-stage midshaft or distal hypospadias repair, with 161 completing 3-month follow-up.
- Children were randomized to caudal block (n=79 analyzed) or penile block (n=82 analyzed), both under general anesthesia.
- Urethrocutaneous fistula occurred in 8.9% of caudal and 7.3% of penile block patients (RR 0.98; 95% CI 0.35 to 2.76; p=0.9).
- Caudal block was associated with less intraoperative and rescue opioid use and lower PACU FLACC scores, though the authors call these findings exploratory given early termination and wide CIs.
- Randomized trial of 60 children aged 1-10 years undergoing palate surgery, 30 per group, comparing two regional techniques.
- Compared bilateral suprazygomatic maxillary nerve blocks (SZMNB) with greater palatine nerve blocks (GPNB) for early postoperative feeding and pain.
- Oral feeding in the first 24 hours was higher with SZMNB (median 80% [70-90%]) than GPNB (median 60% [40-70]), p<0.00001.
- SZMNB also gave lower pain scores over 0-12 hours and fewer patients needed rescue paracetamol (p<0.05), with the authors favoring SZMNB.
- Randomized controlled trial of 68 breast cancer patients (34 per arm) undergoing quadrantectomy, comparing opioid-free general anesthesia with locoregional blocks against opioid-based general anesthesia.
- The primary endpoint was the neutrophil-to-lymphocyte ratio (NLR), measured before surgery and at 1 and 24 hours after; secondary endpoints included side effects, pain management, and inflammatory cytokines.
- In the opioid-based arm, NLR rose from baseline at 1 hour (median change +0.13, IQR 0.01 to 0.62, p<0.0001) and 24 hours (+0.64, IQR 0.28 to 1.03, p<0.0001), while the opioid-free arm showed no significant change.
- The authors conclude that opioid-free anesthesia was associated with a reduced postoperative inflammatory response without compromising pain control, and it was better tolerated with fewer side effects.
- A registry-based cross-sectional study of 74 adult interventional regional anesthesia trials initiated 2017-2024 that had posted results and linked publications on ClinicalTrials.gov.
- The authors compared the earliest and most recent registry versions of each trial's outcome fields to identify changes in outcome definitions, timing, and classifications.
- 91.9% of trials had at least one substantive outcome change, and 37.8% had high-impact modifications. The latest substantive change came after primary completion in 47.1% and after publication in 51.5%.
- None of these latest modifications were disclosed, and secondary outcomes were added or removed more often than primary outcomes.
- Single-center, blinded-assessor randomized trial of 76 adults undergoing elective open cardiac surgery via median sternotomy.
- Bilateral serratus posterior superior intercostal plane block (SPSIPB) was compared with bilateral parasternal plane block plus chest drain-site infiltration (PSIPB), both performed preoperatively under ultrasound guidance.
- Cumulative 24-hour opioid consumption was lower with SPSIPB (mean difference 20.1 MME, 95% CI 11.7-28.5; p < 0.001) in the 33 and 31 patients analyzed.
- The authors report higher 24-hour QoR-15 scores with SPSIPB (median difference 10 points, 95% CI 6-15), above the 6-point minimal clinically important difference, with no difference in adverse events.
- Prospective randomized trial of 80 ultrasound novices (60 medical students, 20 anesthesiology residents), with 78 completing, comparing B-mode training alone against AI-assisted nerve tracking training.
- Participants received a standardized lecture and 10-minute hands-on session, then were assessed with the AI function disabled; the AI group used the NerveTrack real-time tracking system.
- First-attempt independent identification did not differ for the median nerve (57.5% vs 65.8%, RR 1.14, 95% CI 0.81 to 1.62, p=0.452) or the brachial plexus (35.0% vs 42.1%, RR 1.20, 95% CI 0.68 to 2.11, p=0.519).
- The AI-assisted group reported higher brachial plexus confidence after additional AI-assisted training (4.7±0.5 vs 4.4±0.9, p=0.046), while the authors conclude brief AI training did not improve immediate independent identification.
- Single-center, randomized, participant- and assessor-blinded, sham-controlled trial of 120 adults undergoing arthroscopic shoulder surgery with single-shot interscalene block.
- Patients received either active transcutaneous auricular vagus nerve stimulation or sham stimulation, applied perioperatively and on postoperative days 1 and 2.
- Rebound pain occurred in 20.0% of the taVNS group versus 43.3% of the sham group (absolute risk reduction 23.3%, 95% CI 7.2% to 39.5%; p=0.006).
- Secondary results showed modestly lower pain scores and better recovery and sleep, with no added adverse events; sufentanil use did not differ significantly.
- Randomized, placebo-controlled, double-blinded crossover-style study in 20 healthy participants testing topical drugs on peripheral sensory nerve excitability.
- Compared topical 5% lidocaine, 10% phenytoin and 2% mepyramine against placebo, measuring perception threshold changes with a new sodium channel nociceptor testing protocol.
- Perception threshold increases differed between drugs (P < 0.01) and versus placebo (P < 0.01), except phenytoin (P = 0.22), which did not differ significantly.
- Authors report a computational model suggesting lidocaine and mepyramine alter Nav1.7, 1.8 and 1.9 currents differently, supporting the protocol for probing subtype-specific pharmacology.
AI summary not available. Read the source abstract on PubMed.
- Randomized, participant- and assessor-blinded trial of 94 patients undergoing primary unilateral total knee arthroplasty.
- Compared a single-injection adductor canal block with perineural dexamethasone against the same block followed by a continuous adductor canal catheter infusing 0.2% ropivacaine for 50 hours.
- No significant difference in opioid use at 24-48 hours (median 30 mg vs 38.8 mg; 95% CI -22.50 to 7.00 mg; p=0.213), and PACU opioid use was also not significantly different (p=0.081).
- Catheter-associated buckling occurred in 7% of the continuous group versus 0% of the single-injection group, all transient; the authors concluded the catheter did not reduce opioid use.
- Randomized, blinded two-period crossover trial in 10 female sheep receiving ultrasound-guided sciatic nerve injections.
- Compared 200 mg ropivacaine in a poloxamer-alginate in situ-forming hydrogel against 200 mg plain ropivacaine solution.
- Hydrogel prolonged sensory block (median 60 vs 24 hours) and motor block (median 60 vs 16 hours), with lower early plasma peak (Cmax 558 vs 5101 nmol/L).
- Histopathology showed more pronounced, persistent tissue degeneration, necrosis and inflammation with the hydrogel, so the authors judged it unclear whether prolonged effect reflected sustained release or toxicity.
- Prospective, randomized, single-center trial of 90 adults (89 completed) undergoing elective laparoscopic cholecystectomy, allocated to single-injection, multi-injection, or no-block groups.
- Ultrasound-guided unilateral subcostal TAP block was given as a single injection or as multiple injections, compared with no block.
- The multi-injection group had the lowest 24-hour tramadol use and lower VAS scores at 1, 6, and 24 hours (P<0.05), with PONV-free rates of 92% vs 64% vs 52% (P=0.007).
- The authors conclude both block types gave effective analgesia, with the multi-injection technique showing superior pain control and higher patient satisfaction (P<0.001).
- Single-center, double-blind randomized trial of 60 adults undergoing ACL reconstruction, randomized to CFNB or CACB, with 57 completing the study.
- Both groups received a 20 mL 0.5% ropivacaine loading dose and a 0.2% ropivacaine discharge infusion, comparing continuous femoral with continuous adductor canal blockade.
- Average NRS pain over 48 hours did not differ (estimated effect -0.31 points, p=0.58, 95% CI -1.39 to 0.77).
- In an exploratory analysis, fewer CFNB patients required more than 50 MME over 48 hours (5/28 vs 13/29; p=0.045), which the authors call hypothesis-generating.
- Single-center randomized trial of 98 adults undergoing elective unilateral total knee arthroplasty, with patients, surgeons, and outcome assessors blinded.
- Opioid-sparing anesthesia built on esketamine and dexmedetomidine was compared with conventional opioid-based anesthesia, and both groups had a femoral nerve block and multimodal analgesia.
- At 24 hours, QoR-15 was higher with opioid-sparing anesthesia (118.4 vs 113.3; adjusted difference 5.12, 95% CI 0.51-9.74; P=0.029), and this persisted at 48 hours.
- The authors concluded the strategy improved early QoR-15 scores, but the difference did not reach the minimal clinically important difference; lower PONV, lower CRP, and better 1-month Oxford Knee Score were also reported.
- Randomized controlled trial of 92 adults undergoing elective unilateral total hip arthroplasty under spinal anesthesia at a tertiary care operating room.
- Patients received either an ultrasound-guided PENG block or an anterior quadratus lumborum block, each with 30 ml 0.25% ropivacaine plus 4 mg dexamethasone, given 20 minutes before surgery.
- Total 24-hour fentanyl consumption did not differ significantly (237.5 vs 250 μg; p = 0.617), and time to first rescue analgesia was similar (198 vs 241 minutes; p = 0.120).
- The authors found no difference in opioid use, pain scores, or adverse event rates between the two blocks, including intraoperative hemodynamic changes and PONV.
- Randomised, double-blind, placebo-controlled two-centre trial of 58 analysed women undergoing Caesarean delivery under spinal anaesthesia.
- Compared bilateral lateral QLB with 20 ml 0.5% ropivacaine, intrathecal morphine 100 μg with sham block, or both combined.
- Noninferiority of QLB versus ITM for QoR-40 at 24 h was inconclusive (mean difference -0.9; 90% CI -0.9 to 13.5), while QLB reduced resting pain at 6 h versus ITM (MD 2.9, 95% CI 1.3 to 4.5; P<0.001).
- ITM+QLB further reduced early resting and coughing pain and worst pain at 24 h versus ITM alone, and pruritus was more frequent with QLB-containing groups but mostly mild.
- Prospective, single-center, randomized controlled trial of 60 adults undergoing elective VATS, split 30 per group.
- Ultrasound-guided serratus posterior superior intercostal plane block was compared with thoracic paravertebral block, each using 30 mL of 0.25% bupivacaine before induction.
- 24-hour opioid consumption did not differ between groups (66.8 ± 29.4 mg vs 77.2 ± 40.0 mg; mean difference -10.4 mg; 95% CI -36.1 to 15.3; p = 0.439).
- Pain scores and opioid-related adverse effects were similar at all time points, and the authors suggest the serratus block may be an effective alternative given its simpler application.
- Single-center, double-blind, placebo-controlled randomized trial of 160 adults undergoing thyroidectomy under general anesthesia.
- Participants received bilateral superficial cervical plexus blocks with 0.25% bupivacaine or saline, with all receiving multimodal analgesia.
- Quality of recovery (QoR-40) on postoperative day 1 did not differ: 174 versus 173, adjusted mean difference 0.91 (95% CI, -3.57 to 5.40; P = 0.688).
- The bupivacaine group used less PACU opioid (P = 0.017) and fewer needed rescue antiemetics (3 [3.8%] vs 13 [16%]; P = 0.011).
- This double-blind randomized trial enrolled 240 adults undergoing open heart surgery via sternotomy who had bilateral indwelling erector spinae catheters, at one large academic hospital.
- Participants were randomized to programmed intermittent boluses or continuous infusion of ropivacaine 0.2% through an electronic pump.
- The primary outcome, 72-hour opioid consumption in OMME, did not differ significantly: 1.08-fold greater with boluses (95% CI, 0.90-1.31; p = 0.40).
- No secondary outcomes differed significantly, and the authors concluded that intermittent boluses did not reduce early opioid use compared with continuous infusion.
- A prospective randomized trial at a single tertiary university hospital enrolled 57 patients undergoing elective thoracotomy.
- Patients received preoperative ultrasound-guided paravertebral block or erector spinae plane block at T5 with 20 mL of 0.25% bupivacaine, with remifentanil titrated using the NOL index.
- Intraoperative remifentanil use was lower with PVB (431.4 vs 863.6 mcg, p < 0.001), as was 24-hour postoperative morphine (15.2 vs 20.1 mg, p = 0.002).
- Resting NRS scores were lower with PVB at 9 and 12 hours, and cough NRS scores were lower at all time points; the authors conclude ESPB may be insufficient for major thoracic surgery.
- Triple-masked, placebo-controlled randomized trial of 50 adults (25 per arm) undergoing outpatient percutaneous nephrolithotomy.
- Participants all received a preoperative single-injection erector spinae block, then were randomized to continuous bupivacaine 0.25% or saline placebo via perineural catheter for about 57 hours.
- Average daily pain (3.5 vs 3.0; difference 0.25, 95% CI -1.0 to 1.5, P=0.538) and cumulative oxycodone (10 vs 15 mg; difference 0, 95% CI -15 to 5, P=0.358) did not differ significantly between groups.
- The authors found no benefit from adding a continuous block; maximum daily pain, sleep disturbance, and Brief Pain Inventory interference also showed no significant differences.
- Single-center randomized controlled trial in 50 children (general anesthesia alone) and 51 children (general anesthesia plus block), aged 4 to 12, undergoing thoracoscopic mediastinal tumor resection.
- General anesthesia alone was compared with general anesthesia plus a preincision, ultrasound-guided, single-level thoracic paravertebral block.
- 24-hour FLACC pain area under the curve was lower with the block: 41.3/240 vs 53.0/240, mean difference -11.8 (95% CI -14.2 to -9.34; p < 0.001).
- The authors also report higher QoR-15 scores at 24 hours, lower early pain scores, and reduced opioid use and hospital stay with the block.
- Double-blinded, placebo-controlled RCT at two Danish university hospitals, with 100 of 113 randomized patients undergoing non-emergent CABG analyzed.
- Surgeon-administered intraoperative sternal and chest wall infiltration with bupivacaine, epinephrine, clonidine, and dexamethasone (62.5 mL) was compared with saline placebo.
- No difference in opioid use over the first 24 postoperative hours: median 62.3 mg versus 64.0 mg oral morphine equivalents (p = 0.649).
- No secondary or safety endpoints differed significantly, and the authors concluded the intervention did not reduce opioid consumption or add clinical benefit.
- Multicentre, double-blind randomised trial at two tertiary paediatric surgery centres, enrolling 96 children aged 3 to 15 undergoing laparoscopic appendicectomy (46 TAP, 50 infiltration).
- Ultrasound-guided TAP block was compared with local anaesthetic wound infiltration of trocar sites, both using levobupivacaine and standardised multimodal analgesia including paracetamol, ketoprofen, phloroglucinol and nalbuphine.
- Total 24-hour nalbuphine dose was 0.2 [0.0 to 0.2] mg/kg in both groups (P = 0.95), and FLACC scores did not differ (P = 0.78).
- Time to first nalbuphine dose and time to first mobilisation did not differ significantly (log-rank P = 0.095 and 0.18). The authors concluded TAP block gave no greater opioid-sparing effect than wound infiltration.